Category Archives: Commercialization

Specialty Pharmaceutical Hub Services News Roundup: July 2023

AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies

Specialty Pharmaceutical Hub Services News Roundup: June 2023

Specialty Hub Services News Roundup: June 2023 includes information on EVERSANA, Fishawack Health, Integrichain and RxLightning

Xspray Pharma Partners with EVERSANA for Launch and Commercialization of Dasynoc (XS004)

Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Oak Hill Capital Announced the Formation of Petauri Health

Oak Hill Capital partnered with Dan Renick to launch Petauri Health, a purpose-built pharmaceutical commercialization services platform

Trinity Life Sciences Adds Capabilities to Remain in the Forefront of Life Sciences Commercialization

The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults

Novo Holdings Acquires Life Science Commercialization Firm MKG

MedicalKnowedgeGroup (MKG) companies address the business needs of biopharmaceutical companies through the provision of network-mapping analytics, patient-finding analytics, and multi-channel marketing solutions